Post-offer ad filed for Bliss GVS Pharma open offer by Anupam Rasayan

Listed Co AcquisitionOpen Offer TriggeredStrategic Transactions View source PDF Explain this filing

BLISSGVS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.4%Reaction day

₹630.00

prior close

₹626.00

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.6%+3.0% vs market

Pharmaceuticals peers, median of 171sector-0.2%+2.6% vs sector

On the reaction day the stock moved 3.0 pts more than Nifty Microcap 250 and 2.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+2.2

10m

+2.6

15m

+3.0

30m

+3.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.4-0.6+3.0-0.2+2.6

Next day

+1.1+0.0+1.1+0.2+0.9

+6.6+0.7+5.9+0.1+6.4

+10.0+1.1+8.9+0.6+9.4

+14.0+1.6+12.3+0.8+13.2

+11.9+1.5+10.4+0.0+11.9

+14.4+1.4+13.1+0.5+13.9

15d

+9.2+0.4+8.8+0.7+8.5

+5.6-1.4+7.0-2.1+7.7

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 171Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Post-offer advertisement filed for Anupam Rasayan India open offer to acquire up to 26 percent stake in Bliss GVS Pharma at Rs 299 per share. The offer from 28 July to 10 August 2026 saw very weak response with only 1,669 shares tendered versus 2.77 crore shares on offer, resulting in payment of just Rs 4.99 lakh. The underlying share purchase agreement for 42.95 percent stake acquisition is still to be completed.

Likely market impact

Very weak public tendering suggests shareholders found the offer price unappealing. Main acquisition under SPA remains pending.